Should you invest in Netflix, Micron Technology, Workday, Qualcomm, or Facebook?

PR Newswire

NEW YORK, Dec. 31, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for NFLX, MU, WDAY, QCOM, and FB.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/should-you-invest-in-netflix-micron-technology-workday-qualcomm-or-facebook-301199695.html

SOURCE InvestorsObserver

TMX Group, Avino, C-Suite at The Open

Canada NewsWire

TORONTO, Dec. 31, 2020 /CNW/ – David Wolfin, President & CEO, Avino Silver & Gold Mines Ltd. (TSX: ASM), shares his company’s story in an interview with TMX Group.

The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html.


About Avino Silver & Gold Mines Ltd. (TSX: ASM)

Avino Silver & Gold Mines Ltd. is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper. The company generates most of its revenues through the sale of silver produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others. For more information visit: http://www.avino.com/ 


About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited

Tekla Life Sciences Investors Paid Distribution

Tekla Life Sciences Investors Paid Distribution

BOSTON–(BUSINESS WIRE)–
On December 31, 2020, Tekla Life Sciences Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $180,403,667, of which $177,263,254 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on December 31, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source.

 

Current Distribution

Percentage Breakdown of Current Distribution

Total Cumulative Distributions for the Fiscal Year to Date1

Percentage Breakdown of the Total Cumulative Distributions for the Fiscal Year to Date1

Net Investment Income

$0.0000

0%

$0.0000

0%

Net Realized ST Cap Gains

$0.3900

98%

$0.3900

98%

Net Realized LT Cap Gains

$0.0100

2%

$0.0100

2%

Return of Capital or Other Capital Source

$0.0000

0%

$0.0000

0%

TOTAL (per common share):

$0.4000

100%

$0.4000

100%

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from October 31, 2015 through October 31, 2020

4.97%

Annualized current distribution rate expressed as percentage of NAV as of October 31, 2020

8.21%

Cumulative total return at NAV for the fiscal year, through October 31, 20202

-3.07%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of October 31, 20201

2.05%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of net assets under management as of September 30, 2020. Tekla also serves as investment adviser to Tekla Healthcare Investors (NYSE: HQH), Tekla Healthcare Opportunities Fund (NYSE: THQ) and Tekla World Healthcare Fund (NYSE: THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Destra Capital Advisors is the Fund’s marketing and investor support services agent. Please contact Destra Capital Investments at [email protected] or call (877) 855-3434 if you have any questions regarding HQL.

1 The Fund’s current fiscal year began on October 1, 2020.

2 Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2020 through October 31, 2020.

Destra Capital Investments

[email protected]

(877) 855-3434

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Other Professional Services Professional Services Finance

MEDIA:

Tekla Healthcare Opportunities Fund Paid Distribution

Tekla Healthcare Opportunities Fund Paid Distribution

BOSTON–(BUSINESS WIRE)–
On December 31, 2020, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $110,338,313 of which $118,353,455 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on December 31, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you have invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’. All amounts are expressed per common share.

 

Current

Distribution

Percentage

Breakdown of

Current Distribution

Total Cumulative Distributions for the

Fiscal Year to Date1

Percentage Breakdown

of the Total Cumulative Distributions for the

Fiscal Year to Date1

Net Investment Income

$0.0139

12%

$0.0341

10%

Net Realized ST Cap Gains

$0.0000

0%

$0.0000

0%

Net Realized LT Cap Gains

$0.0000

0%

$0.0085

3%

Return of Capital or Other Capital Source

$0.0986

88%

$0.2949

87%

TOTAL (per common share):

$0.1125

100%

$0.3375

100%

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from November 30, 2015 through November 30, 2020

9.83%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020

6.43%

Cumulative total return at NAV for the fiscal year, through November 30, 20202

4.88%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of November 30, 20201

1.61%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla Healthcare Opportunities Fund (NYSE: THQ) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of assets under management as of September 30, 2020. Tekla also serves as investment adviser to Tekla Healthcare Investors (NYSE: HQH), Tekla Life Sciences Investors (NYSE: HQL) and Tekla World Healthcare Fund (NYSE: THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at [email protected] or call (877) 855-3434 if you have any questions regarding THQ.

1

  The Fund’s current fiscal year began on October 1, 2020.

2

 

Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2020 through November 30, 2020.

 

Destra Capital Advisors

[email protected]

(877) 855-3434

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Tekla World Healthcare Fund Paid Distribution

Tekla World Healthcare Fund Paid Distribution

BOSTON–(BUSINESS WIRE)–
On December 31, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $26,990,930, of which $33,792,319 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on December 31, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you have invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’. All amounts are expressed per common share.

 

Current

Distribution

Percentage

Breakdown of Current

Distribution

Total Cumulative

Distributions for the

Fiscal Year to Date1

Percentage Breakdown

of the Total Cumulative

Distributions for the

Fiscal Year to Date1

Net Investment Income

$0.0000

0%

$0.0000

0%

Net Realized ST Cap Gains

$0.0000

0%

$0.0000

0%

Net Realized LT Cap Gains

$0.0000

0%

$0.0000

0%

Return of Capital or Other Capital Source

$0.1167

100%

$0.3501

100%

TOTAL (per common share):

$0.1167

100%

$0.3501

100% 

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from November 30, 2015 through November 30, 2020

 

5.41%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020

 

9.70%

Cumulative total return at NAV for the fiscal year, through November 30, 20202

 

3.78%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of November 30, 20201

 

2.43%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla World Healthcare Fund (NYSE: THW) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of assets under management as of September 30, 2020. Tekla also serves as investment adviser to Tekla Healthcare Investors (NYSE: HQH), Tekla Life Sciences Investors (NYSE: HQL) and Tekla Healthcare Opportunities Fund (NYSE: THQ), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at [email protected] or call (877) 855-3434 if you have any questions regarding THW.

1 The Fund’s current fiscal year began on October 1, 2020.

2 Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2020 through November 30, 2020.

Destra Capital Advisors

(877) 855-3434

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Tekla Healthcare Investors Paid Distribution

Tekla Healthcare Investors Paid Distribution

BOSTON–(BUSINESS WIRE)–
On December 31, 2020, Tekla Healthcare Investors paid a distribution of $0.48 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $339,669,246, of which $333,469,826 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on December 31, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. All amounts are expressed per common share.

 

 

Current

Distribution

 

Percentage

Breakdown of

Current Distribution

 

Total Cumulative

Distributions for the

Fiscal Year to Date1

 

Percentage Breakdown

of the Total Cumulative

Distributions for the

Fiscal Year to Date1

Net Investment Income

 

$0.0000

 

0%

 

$0.0000

 

0%

Net Realized ST Cap Gains

 

$0.4380

 

91%

 

$0.4380

 

91%

Net Realized LT Cap Gains

 

$0.0420

 

9%

 

$0.0420

 

9%

Return of Capital or Other Capital Source

 

$0.0000

 

0%

 

$0.0000

 

0%

TOTAL (per common share):

 

$0.4800

 

100%

 

$0.4800

 

100%

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from October 31, 2015 through October 31, 2020

 

3.41%

Annualized current distribution rate expressed as a percentage of NAV as of October 31, 2020

 

8.25%

Cumulative total return at NAV for the fiscal year, through October 31, 20202

 

-3.20%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of October 31, 20201

 

2.06%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla Healthcare Investors (NYSE: HQH) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.1 billion of assets under management as of September 30, 2020. Tekla also serves as investment adviser to Tekla Life Sciences Investors (NYSE: HQL), Tekla Healthcare Opportunities Fund (NYSE: THQ) and Tekla World Healthcare Fund (NYSE: THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at [email protected] or call (877) 855-3434 if you have any questions regarding HQH.

1

The Fund’s current fiscal year began on October 1, 2020.

2

Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2020 through October 31, 2020.

 

Destra Capital Advisors

(877) 855-3434

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Professional Services Health Other Professional Services Other Health Managed Care Finance General Health

MEDIA:

IIROC Trade Resumption – SONA

Canada NewsWire

VANCOUVER, BC, Dec. 31, 2020 /CNW/ – Trading resumes in:

Company: Sona Nanotech Inc.

CSE Symbol: SONA

All Issues: No

Resumption (ET): 10:03:57 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC)

Access-Power & Co., Inc. is pleased to announce that we formally reported our past CEO with financial Crimes against the Company to the SEC; and is also pleased to announce the completion of our 10K for 2020, which will be filed on January 4, 2021

GRAND HAVEN, Mich., Dec. 31, 2020 (GLOBE NEWSWIRE) — Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to formally charge our past CEO, Mark Lee Baum, with financial crimes. The Company estimates these financial crimes were committed against its Shareholders between 2002-2008. The Company today has emailed our Section 11 Chief Legal at the SEC a report of the alleged charges.

In addition, and most importantly, the Company today has completed our 2020 10K. This report will be filed with the SEC on January 4, 2021. We understand that there is a requirement for a PCAOB SEC Accountant with this filing. We ask our officers and esteemed attorneys in our Section 11 to please give us some more time with this requirement.

Patrick J. Jensen, our sole Director commented, “It is with great pleasure to be able to report a 2020 Y.E. cash balance of $32,700.13 in our checking account. We also end the year with a balance sheet that contains ZERO LONG TERM DEBT. We will be filing a re-application to go PINK CURRENT INFORMATION tier with OTC Markets on January 24, 2021.”

We wish all of our Shareholders a Happy New Year!

Established in 1996, Access-Power, Inc. is a Florida based for-profit Corporation with operations in West Michigan.

There are various risk factors that should be carefully considered in evaluating our business; because such factors may have a significant impact on our business, our operating results, our liquidity and financial condition. As a result of these various risk factors, actual results could differ materially from those projected in any forward-looking statements. Additional risks and uncertainties not presently known to us, or that we currently consider to be immaterial, may also impact our business, result of operations, liquidity and financial condition. If any such risks occur, our business, its operating results, liquidity and financial condition could be materially affected in an adverse manner. Under such circumstances, if a stable trading market for our securities is established, the trading price of our securities could decline, and you may lose all or part of your investment.

SECURITIES ISSUED BY THE COMPANY INVOLVE A HIGH DEGREE OF RISK AND, THEREFORE, SHOULD BE CONSIDERED EXTREMELY SPECULATIVE. THEY SHOULD NOT BE PURCHASED BY PERSONS WHO CANNOT AFFORD THE POSSIBILITY OF THE LOSS OF THE ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD READ ALL OF THE COMPANY’S FILINGS, INCLUDING ALL EXHIBITS, AND CAREFULLY CONSIDER, AMONG OTHER FACTORS THE VARIOUS RISK FACTORS THAT MAY BE PRESENT.

BEWARE OF NAKED SHORTING IN OUR COMMON SHARES

You should be aware that there are many substantial risks to an investment in our common stock. Carefully consider these risk factors, along with any available information currently reported by the Company (of which there are note), before you decide to invest in shares of our common stock.   If these risk factors were to occur, our business, financial condition, results of operations or future prospects could be materially adversely affected. If that happens, the market price for our common stock, if any, could decline, and prospective investors would likely lose all or even part of their investment.

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about the Company’s business, based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors.
Contact Information:

Patrick J. Jensen
Director
Tel:  616.312.5390
Email:  [email protected]
Corporate Website:  http://www.myaccess-power.com
“Our corporate website is currently under construction to soon reflect our new business model in the Michigan Medical Marijuana Clone sector.”

Product Website
http://www.mycbdpets.com

http://www.clonesbydrones.com

http://www.clonesbycars.com

Access-Power & Co., Inc. 
OTC Ticker:  ACCR



Eaton Vance Closed-End Funds Release Estimated Sources Of Distributions

PR Newswire

BOSTON, Dec. 31, 2020 /PRNewswire/ — The Eaton Vance closed-end funds listed below released today the estimated sources of their December distributions (each a “Fund”).  This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission.  The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the December distribution.  It is not determinative of the tax character of a Fund’s distributions for the 2020 calendar year. Shareholders should note that each Fund’s total regular distribution amount is subject to change as a result of market conditions or other factors.


IMPORTANT DISCLOSURE
:  You should not draw any conclusions about each Fund’s investment performance from the amount of this distribution or from the terms of each Fund’s Plan.  Each Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur for example, when some or all of the money that you invested in each Fund is paid back to you. A return of capital distribution does not necessarily reflect each Fund’s investment performance and should not be confused with “yield” or “income.”  The amounts and sources of distributions reported in this notice are only estimates and are not being provided for tax reporting purposes.  The actual amounts and sources of the amounts for accounting and/or tax reporting purposes will depend upon each Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. Each Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

The following tables set forth estimates of the sources of each Fund’s December distribution and its cumulative distributions paid for its fiscal year through December 31, 2020, and information relating to each Fund’s performance based on its net asset value (NAV) for certain periods.



Eaton Vance Enhanced Equity Income Fund (NYSE: EOI)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0898

Distribution Frequency:

Monthly

Fiscal Year End:

September

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal
Year-to-Date

% of the Cumulative
Distributions for the Fiscal
Year-to-Date

Net Investment Income

$0.0037

4.10%

$0.0145

5.40%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0861

95.90%

$0.2549

94.60%

Total per common share

$0.0898

100.00%

$0.2694

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

10.83%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

6.57%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

5.78%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

1.10%



Eaton Vance Enhanced Equity Income Fund II (NYSE: EOS)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

0.0988

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0000

0.00%

$0.0000

0.00%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0107

0.90%

Return of Capital or Other Capital Source(s)

$0.0988

100.00%

$1.1749

99.10%

Total per common share

$0.0988

100.00%

$1.1856

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

14.78%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

5.81%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

23.25%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

4.84%



Eaton Vance Risk-Managed Diversified Equity Income Fund (NYSE: ETJ)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0760

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0052

6.90%

$0.0675

7.40%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0708

93.10%

$0.8445

92.60%

Total per common share

$0.0760

100.00%

$0.9120

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

7.69%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

9.20%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

15.90%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

8.44%



Eaton Vance Tax-Advantaged Dividend Income Fund  (NYSE: EVT)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.1450

Distribution Frequency:

Monthly

Fiscal Year End:

October

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0503

34.70%

$0.1003

34.60%

Net Realized Short-Term Capital Gains

$0.0249

17.20%

$0.0325

11.20%

Net Realized Long-Term Capital Gains

$0.0698

48.10%

$0.1572

54.20%

Return of Capital or Other Capital Source(s)

$0.0000

0.00%

$0.0000

0.00%

Total per common share

$0.1450

100.00%

$0.2900

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

10.42%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

7.27%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

14.55%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

0.61%



Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund  (NYSE: ETO)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.1425

Distribution Frequency:

Monthly

Fiscal Year End:

October

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0263

18.50%

$0.0539

18.90%

Net Realized Short-Term Capital Gains

$0.1162

81.50%

$0.2160

75.80%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0151

5.30%

Return of Capital or Other Capital Source(s)

$0.0000

0.00%

$0.0000

0.00%

Total per common share

$0.1425

100.00%

$0.2850

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

11.12%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

6.70%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

14.74%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

0.56%



Eaton Vance Tax-Managed Buy-Write Income Fund (NYSE: ETB)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.1080

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions

for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0259

24.00%

$0.1296

10.00%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0705

65.30%

$0.3914

30.20%

Return of Capital or Other Capital Source(s)

$0.0116

10.70%

$0.7750

59.80%

Total per common share

$0.1080

100.00%

$1.2960

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

6.80%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

9.08%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

2.08%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

8.32%



Eaton Vance Tax-Managed Buy-Write Opportunities Fund (NYSE: ETV)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.1108

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0164

14.80%

$0.0718

5.40%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0944

85.20%

$1.2578

94.60%

Total per common share

$0.1108

100.00%

$1.3296

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

8.73%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

9.40%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

5.85%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

8.61%



Eaton Vance Tax-Managed Diversified Equity Income Fund (NYSE: ETY)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0843

Distribution Frequency:

Monthly

Fiscal Year End:

October

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0031

3.70%

$0.0064

3.80%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0812

96.30%

$0.1622

96.2%

Total per common share

$0.0843

100.00%

$0.1686

100.0%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

10.00%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

8.13%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

8.08%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

0.68%



Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund (NYSE: ETW)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0727

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions

for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0037

5.10%

$0.0750

8.60%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0596

82.00%

$0.3167

36.30%

Return of Capital or Other Capital Source(s)

$0.0094

12.90%

$0.4807

55.10%

Total per common share

$0.0727

100.00%

$0.8724

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

6.64%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

8.75%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

4.29%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

8.02%



Eaton Vance Tax-Advantaged Global Dividend Income (NYSE: ETG)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.1025

Distribution Frequency:

Monthly

Fiscal Year End:

October

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0185

18.00%

$0.0369

18.00%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0840

82.00%

$0.1681

82.00%

Total per common share

$0.1025

100.00%

$0.2050

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

9.39%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

6.63%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

15.47%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

0.55%



Eaton Vance Tax-Managed Global Diversified Equity Income Fund (NYSE: EXG)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0616

Distribution Frequency:

Monthly

Fiscal Year End:

October

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions
for the Fiscal Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0009

1.40%

$0.0025

2.00%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0607

98.60%

$0.1207

98.00%

Total per common share

$0.0616

100.00%

$0.1232

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

8.39%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

8.27%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

11.32%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

0.69%



Eaton Vance Tax-Managed Buy-Write Strategy Fund (NYSE: EXD)

Distribution Period: 

December- 2020

Distribution Amount per Common Share: 

$0.0708

Distribution Frequency:

Monthly

Fiscal Year End:

December

Source

Current Distribution

% of Current Distribution

Cumulative
Distributions

for the Fiscal

Year-to-Date

% of the Cumulative
Distributions for the Fiscal Year-to-Date

Net Investment Income

$0.0023

3.20%

$0.0238

2.80%

Net Realized Short-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Net Realized Long-Term Capital Gains

$0.0000

0.00%

$0.0000

0.00%

Return of Capital or Other Capital Source(s)

$0.0685

96.80%

$0.8258

97.20%

Total per common share

$0.0708

100.00%

$0.8496

100.00%

Average annual total return at NAV for the 5-year period ended on November 30, 2020 1

2.71%

Annualized current distribution rate expressed as a percentage of NAV as of November 30, 2020 2

8.20%

Cumulative total return at NAV for the fiscal year through November 30, 2020 3

6.91%

Cumulative fiscal year to date distribution rate as a percentage of NAV as of November 30, 2020 4

7.52%


1 Average annual total return at NAV represents the change in NAV of the Fund, with all distributions reinvested, for the 5-year period ended  

  on November 30, 2020


2 The annualized current distribution rate is the cumulative distribution rate annualized as a percentage of the Fund’s NAV as of November 30,2020


3 Cumulative total return at NAV is the percentage change in the Fund’s NAV for the period from the beginning of its fiscal year to November 30, 2020

   including distributions paid and assuming reinvestment of those distributions.


4 Cumulative fiscal year distribution rate for the period from the beginning of its fiscal year to November 30, 2020 measured on the dollar value of the

  distributions in year-to-date period as a percentage of the Fund’s NAV as of November 30, 2020

 

Cision View original content:http://www.prnewswire.com/news-releases/eaton-vance-closed-end-funds-release-estimated-sources-of-distributions-301199693.html

SOURCE Eaton Vance Management

Material Fact – Corporate restructuring related to Itaú’s equity interest in XP Inc.’s capital stock

PR Newswire

SÃO PAULO, Dec. 31, 2020 /PRNewswire/ — Itaú Unibanco Holding S.A. (“Itaú Unibanco” or “Company”), in accordance with Article 157, paragraph 4, of Law No. 6,404/1976 (“Brazilian Corporate Law”), and CVM Instruction No. 358/2020, both as amended, and Article 3 combined with Attachment 3 to CVM Instruction No. 565/2015, announces to its stockholders and the market in general, in line with the Material Facts disclosed on November 3 and 26, 2020, that, as of this date, the Company’s Board of Directors called the Extraordinary General Stockholders’ Meeting (“ESM”) to be held on January 31, 2021, according to the Call Notice disclosed as of this date, to resolve on the proposal for a corporate restructuring aimed at segregating Itaú Unibanco conglomerate’s business line related to the equity interest in XP Inc.’s capital stock (“XP”), a company headquartered in the Cayman Islands and listed on Nasdaq, represented by two hundred twenty-six million, five hundred twenty-three thousand, three hundred four (226,523,304) shares issued by XP, equivalent, as of September 30, 2020, to 41.05% of the capital of the latter, to a new company (“Newco”) to be incorporated on the date the ESM is held through spin-offs involving the Company (“Transaction”), under the terms and conditions set forth in the protocol and justification for the Transaction, disclosed by the Company as of the same date (“Protocol and Justification”).The percentage of XP’s capital stock to be held by Newco after the Transactions represents, as of this date, 40.52%, taking into account XP’s recent capitalization.

1. Identification of the companies involved in the Transaction and summarized description of their activities

Itaú Unibanco Holding S.A., a publicly-held company enrolled with the Corporate Taxpayer’s Registry of the Ministry of Finance (CNPJ/MF) under No. 60.872.504/0001-23, with its articles of association duly filed with the São Paulo State Board of Trade (JUCESP) under NIRE No. 35.3.0001023-0, and registered before the Brazilian Securities and Exchange Commission (“CVM”) under No. 19348, headquartered at Praça Alfredo Egydio de Souza Aranha, 100, Torre Olavo Setubal, Piso Itaú Unibanco, Parque Jabaquara, City of São Paulo, State of São Paulo, and its corporate purpose is the banking activity in all its authorized forms, including foreign exchange transactions. In addition to being a financial institution, the Company is a holding company that controls many companies of the Itaú Unibanco Conglomerate.

Itaú Unibanco S.A., a closely-held company enrolled with the Corporate Taxpayer’s Registry of the Ministry of Finance (CNPJ/MF) under No. 60.701.190/0001-04, with its articles of association duly filed with the São Paulo State Board of Trade (JUCESP) under NIRE No. 35.3.00023978, headquartered at Praça Alfredo Egydio de Souza Aranha, 100, Torre Olavo Setubal, Parque Jabaquara, City of São Paulo, State of São Paulo, and its corporate purpose is the banking activity in all its authorized forms, including foreign exchange transactions. Itaú Unibanco S.A. is a wholly-owned subsidiary of the Company.

ITB Holding Brasil Participações Ltda., a limited liability company enrolled with the Brazilian Individual Taxpayers’ Registry of the Ministry of Finance (CNPJ/MF) under No. 04.274.016/0001-43, with its articles of association duly filed with the São Paulo State Board of Trade (JUCESP) under NIRE No. 35.2.1922828-0 (“ITB Holding”), headquartered at Praça Alfredo Egydio de Souza Aranha, 100, Torre Conceição, 7º andar, Parque Jabaquara, City of São Paulo, State of São Paulo, and its corporate purpose is to hold equity interest in other companies in Brazil and abroad with the main purpose of coordinating their operational activities through studies, analyses, and suggestions on operating policies and projects for expansion and raising of funds required. ITB Holding has Itaú Unibanco S.A. and the Company as its sole stockholders, at the proportion of 99.9999995% and 0.0000005%, respectively.

2. Description and purpose of the Transaction

The Transaction comprises the following steps:

(i) the partial spin-off of ITB Holding, carried out as of this date, with the transfer of the spun-off portion to Itaú Unibanco S.A., which is solely represented by two hundred twenty-six million, five hundred twenty-three thousand, three hundred four (226,523,304) shares issued by XP (“Spun-off Portion”) (“ITB Holding Spin-off”);

(ii)  the partial spin-off of Itaú Unibanco S.A., with the transfer of the Spun-off Portion to the Company, as approved at the Extraordinary General Stockholders’ Meeting of Itaú Unibanco S.A. held as of this date (“Itaú Unibanco S.A. Spin-off”) and subject to the approval from the Company’s ESM called in this date and to be held on January 31, 2021; and

(iii)  the partial spin-off of the Company, to be resolved on at the ESM called in this date to be held on January 31, 2021, with the transfer of the spun-off stockholders’ equity, composed of the Spun-off Portion plus the amount corresponding to ten million Brazilian reais (R$ 10,000,000.00) (“Company’s Spun-off Portion), to Newco, the company to be incorporated on the same date of the ESM, and the assignment to the Company’s stockholders of 4,958,290,359 common and 4,845,844,989 preferred shares issued by Newco, in the same number, type and proportion of the shares held by these stockholders in the Company itself (“Company Spin-off”), complying with item 9 below.

The purpose of the Transaction is segregating Itaú Unibanco conglomerate’s business line related to the investment in XP into Newco, so that the Company’s stockholders also become Newco’s stockholders and hold the same number, type and proportion of the shares they hold in the Company itself.

3. 
Main benefits, costs and risks of the Transaction

3.1.
Main benefits

After the Transaction is implemented, the Company’s stockholders will receive equity interest in Newco, in the same number, type and proportion of the shares they hold in the Company. Accordingly, the Company’s stockholders will continue to hold the same equity interest they currently do in the Company and will also become stockholders of Newco, whose sole asset will be the investment in XP. This will enable the Company and Newco to operate independently, with well-defined business goals, and also the Company’s stockholders to hold shares issued by both companies, thus being assured a more direct interest in the investment in XP, in a scenario of increased liquidity and with the possibility to increase the market value of their investments. The main benefit of the Transaction is the potential value creation to the Company’s stockholders.

3.2.
Costs

The costs involved in carrying out and implementing the Transaction are estimated at approximately thirteen million Brazilian reais (R$ 13,000,000.00), including expenses on publication of corporate acts and fees payable to independent auditors, appraisers, and other professionals engaged to assist the Transaction.

3.3.
Risks

Considering that (i) the Company already indirectly holds 100% of the shares issued by ITB Holding and that the Company already directly holds 100% of the shares issued by Itaú Unibanco S.A. and, therefore, in the ITB Holding Spin-off, the merger into Itaú Unibanco S.A. of the Spun-off Portion refers to the merger of the stockholders’ equity already indirectly held by the Company; (ii) in the Itaú Unibanco S.A. Spin-off, the merger into the Company of the Spun-off Portion refers to the merger of the stockholders’ equity already indirectly held by the latter; (iii) in the Company Spin-off, the Company’s Spun-off Portion will be transferred to Newco, the company to be incorporated with the same stockholding base of the Company; and (iv) Newco’s activities will be restricted to the ownership of the investment in XP, which is currently indirectly held by the Company, and the Company understands that the Transaction will not increase its risk exposure or impact its activities, the securities it issues and the risks to which stockholders, investors and stakeholders of the Company are already exposed. Accordingly, the Company identifies no risk factors other than those described in “Section 4” of its Reference Form.

As financial institutions, the Company and Itaú Unibanco S.A. are subject to the rules issued by the National Monetary Council (“CMN”) and to the rules and inspection by the Central Bank of Brazil. In this regard, the intended Transaction is dependent upon the approval from the Central Bank of Brazil, in accordance with CMN Resolution No. 4,122/2012.

Additionally, there are risks associated with price variations in shares issued by the Company and, in due course, by Newco, after it starts trading its own shares, and these risks are inherent in capital markets and incurred by all Company’s stockholders, who will also be Newco’s stockholders.

4. 
Ratio of exchange of shares and criteria for its set-up

The Transaction will not involve share exchange as the Spun-off Portion is already included in the Company’s stockholders’ equity, and the Company already holds, directly or indirectly, the totality of the capital stock of ITB Holding and Itaú Unibanco S.A. Accordingly, the merger of the Spun-off Portion into the Company will not result in increase in the Company’s capital or the issue of new shares.

Regarding the partial spin-off of the Company, with the resulting capital reduction and transfer of its Spun-off Portion to Newco, the Company’s stockholders will receive shares issued by Newco in the same number, type and proportion of the shares held by these stockholders in the Company.

5. 
Main assets and liabilities making up each portion of the stockholders’ equity, in case of a spin-
off

The Spun-off Portion, whose net book value determined by PricewaterhouseCoopers Auditores Independentes (“Appraiser”) is eight billion, five hundred eighty-five million, four hundred twenty-three thousand, eight hundred sixty-two Brazilian reais and eighty-five cents(R$ 8,585,423,862.85), as of September 30, 2020, is made up solely of the equity interest in XP’s capital stock, corresponding to two hundred twenty-six million, five hundred twenty-three thousand, three hundred four (226,523,304) shares of its own issue.

The Company’s Spun-off Portion is made up of the Spun-off Portion plus the amount in cash corresponding to ten million Brazilian reais (R$ 10,000,000.00), to be transferred to Newco’s cash to support its initial transactions and the Listing processes (described in item 9 below).

6. 
Whether the transaction was or will be submitted to approval from Brazilian or foreign authorities

The intended Transaction is subject to approval by the Central Bank of Brazil, in accordance with CMN Resolution No. 4,122/2012, and from CADE, the Brazilian anti-trust authority, in accordance with Article 90, item II, of Law No. 12,529/2011, and from regulatory authorities in the United States and in the United Kingdom regarding the inclusion of Newco in XP stockholding network.

7. 
In transactions involving parent companies, subsidiaries or companies under common control the share exchange ratio is calculated in accordance with Article 264 of Brazilian Corporate Law

In the ITB Holding Spin-off, the appraisal provided for in Article 264 of Brazilian Corporate Law is not required, given the absence of minority stockholders and the lack of share exchange  or capital increase in the corresponding new company.

In the Itaú Unibanco S.A. Spin-off, the appraisal provided for in Article 264 of Brazilian Corporate Law is not required, given the absence of minority stockholders and the lack of share exchange or capital increase in the corresponding new company.

In the Company Spin-off, the preparation of the appraisal report addressed by Article 264 of Brazilian Corporate Law is not applicable, given that it is a spin-off transaction of its own and also because Newco’s stockholding base should have the same stockholding structure of the Company, since the Company’s stockholders will receive the same number and type of shares issued by Newco.

8. 
Application of right of dissent and reimbursement amount

No right of dissent will be provided to the Company’s stockholders arising from the Spin-off of the Company, since the Transaction will not result in (i) change of the Company’s corporate purpose; (ii) reduction in mandatory dividend; or (iii) interest in a group of companies, as provided for in Articles 136 and 137 of Brazilian Corporate Law.

As provided for in Article 223 of Brazilian Corporate Law, the term for having Newco’s shares admitted to trading on the secondary market is one hundred twenty days (120) from the date of the ESM, and in case of noncompliance stockholders will be entitled to withdraw from Newco, with the net book value of its shares being reimbursed within thirty (30) days following the end of such term.

9. 
Miscellaneous

Newco will submit a request (i) for registration as a publicly-held company in the “A” category before the Brazilian Securities and Exchange Commission (CVM), in accordance with CVM Instruction No. 480/2009, (ii) so that its shares are listed on B3 S.A.– Brasil, Bolsa, Balcão; and (iii) so that its American Depositary Receipts (“ADRs”) are listed on the New York Stock Exchange – NYSE (jointly referred to as the “Listings”).

The distribution of Newco’s shares and ADRs to the stockholders and holders of ADRs of the Company, as a result of the Company Spin-off, will take place after the Listings, according to the cut-off date and the procedures to be informed in due course.

The shares issued by the Company will continue to be traded with the right to receive the shares issued by Newco until the cut-off date, which, once determined, will be informed to the market through a Notice to Stockholders.

Nevertheless, the Transaction, that is, the legal and accounting segregation of the Company and Newco, will come into force on the date it is approved by stockholders at the Extraordinary General Stockholders’ Meeting (ESM), provided that all previously required authorizations are obtained by said date.

The Protocol and Justification, the Appraisal Report of the Company’s Spun-off Portion, and other information and documents related to the Transaction, including those required by Attachments 20-A and 21 to CVM Instruction No. 481/2009, are attached to the ESM Manual, disclosed as of this date, and are available to the Company’s stockholders at its head office, on the Company’s Investor Relations website (www.itau.com.br/relacoes-com-investidores), and on the websites of CVM (www.cvm.gov.br) and B3 (www.b3.com.br).


RENATO LULIA JACOB


Head of Investor Relations and Market Intelligence

Itaú Unibanco – Comunicação Corporativa

(11) 5019-8880 / 8881 – [email protected]  


 

Cision View original content:http://www.prnewswire.com/news-releases/material-fact—corporate-restructuring-related-to-itaus-equity-interest-in-xp-incs-capital-stock-301199692.html

SOURCE Itaú Unibanco Holding S.A.